Attenuation of influenza virus infectivity with herbal-marine compound (HESA-A): An in vitro study in MDCK cells

Virology Journal

Volumn 9, Issue , 2012, Pages

  Mehrbod, Parvaneh ^a   Ideris, Aini ^a   Omar, Abdul Rahman ^a   Hair Bejo, Mohd ^a   Tan, Sheau Wei ^a   Kheiri, Masoumeh Tavassoti ^b   Tabatabaian, Mansoureh ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cytokine; H1N1; HESA A; IL 6; Influenza virus; TNF

Indexed keywords

ANTIVIRUS AGENT; HESA A; INTERLEUKIN 6; NATURAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; HESA A PREPARATION; HESA-A PREPARATION; IMMUNOLOGIC FACTOR; PLANT MEDICINAL PRODUCT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ATTENUATION; VIRUS INFECTIVITY; ANIMAL; CELL LINE; DOG; DRUG EFFECT; GENE EXPRESSION PROFILING; GROWTH, DEVELOPMENT AND AGING; METABOLISM; ORTHOMYXOVIRUS; PATHOGENICITY; REAL TIME POLYMERASE CHAIN REACTION; SECRETION; VIRULENCE; VIRUS LOAD;

ORTHOMYXOVIRIDAE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; DOGS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; IMMUNOLOGIC FACTORS; INTERLEUKIN-6; ORTHOMYXOVIRIDAE; PLANT PREPARATIONS; REAL-TIME POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS; THIAZOLES; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD; VIRULENCE;

EID: 84856822433     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-44     Document Type: Article

References (25)

1. Wagman P, Leong M, Simmen K: Development of a novel influenza A antiviral assay. J Virol Methods 2002, 105:105-114.
2. Pathumwadee I, Chittima L, Thanyada R, Arthorn L, Maturos M, Panita D, Ornjira A, Krit C, Nopphorn K, Pornthep S, et al: How amantadine and rimantadine inhibit proton transport in the M2 protein channel. J Mol Graph Model 2008, 27:342-348.
3. Moallem S, Ahmadi A, Moshafi M, Taghavi M: Evaluation of fetal toxicity of HESA-A, a natural anticancer agent, in mice. J Kerman Univ Med Sci 2007, 14:124-133.
4. Ahmadi A, Barikbin B, Naseri M, Mohagheghi M: The effect of HESA-A on psoriasis vulgaris. J Drugs Dermatol 2008, 7:559-561.
5. Ahmadi A, Mohagheghi M, Fazeli M, Nahavandian B, Bashardoost N, Musavi-Jarahi A, Gharipoor M: HESA-A, a new treatment for breast cancer and choroidal metastasis. Med Sci Monit 2005, 11:300-303.
6. Cheung C, Poon L, Lau A, Luk W, Lau Y, Shortridge K, Gordon S, Guan Y, Peiris J: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002, 360:1831-1837. (Pubitemid 35449422)
7. Osterholm MT: Preparing for the next pandemic. N Engl J Med 2005, 352:1839-1842.
8. Fedson DS: Confronting an infl uenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008, 8:571-576.
9. Vahabpour RR, Shamsi SM, Monavari SH, Sajjadi SEN: Evaluation of potential antiviral activity of hydroalcoholic extract of Lemon Balm L. against herpes simplex virus type-I. Iran J Virol 2007, 1:28-32.
10. Kitazato K, Wang Y, Kobayashi N: Viral infectious disease and natural products with antiviral activity. Drug Discov Ther 2007, 1:14-22.
11. Kawai T, Akira S: Innate immune recognition of viral infection. Nat Immunol 2006, 7:131-137. (Pubitemid 43135878)
12. Fedson DS: Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin Infec Dis 2006, 43:199-205.
13. Jain MK, Ridker PM: Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nat Rev Drug Discov 2005, 4:977-987.
14. Warne JP: Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J Endocrinol 2003, 177:351-355.
15. Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G, et al: The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4 + T cells. J Exp Med 2009, 206:69-78.
16. Powe JR, Castleman WL: Canine influenza virus replicates in alveolar macrophages and induces TNF-a. Vet Pathol 2009, 46:1187-1196.
17. Ahmadi A, Mohagheghi MA, Karimi M, Golestanha SA, Naseri M: Anticancer effects of HESA-A in patients with metastatic colon cancer. Integr Cancer Ther 2009, 8:71-74.
18. Moallem SA, Ahmadi A, Niapour M, Hosseini T, Habibi G: Role of apoptosis in HESA-A teratogenicity in mouse fetus. Drug Chem Toxicol 2009, 32:186-190.
19. Dhanasekaran S, Doherty TM, Kenneth J: Comparison of different standards for real-time PCR-based absolute quantification. J Immunol Methods 2010, 354:34-39.
20. Bustin SA: Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 2002, 29:23-39.
21. Fu J, Li D, Xia S, Song H, Dong Z, Chen F, Sun X, Tang Z: Absolute quantification of plasmid DNA by real-time PCR with genomic DNA as external standard and its application to a biodistribution study of an HIV DNA vaccine. Anal Sci 2009, 25:675-680.
22. Sadeghi AH, Ahmadi A: Cytotoxicity and antitumor properties of a marine compound, HESA-A, on cancer cells. DARU J Pharmaceutical Sci 2003, 11:82-87.
23. Mehrbod P, Motamed N, Tabatabaian M, Soleimani-Estyar R, Amini E, Shahidi M, Kheiri MT: In vitro antiviral effect of "Nanosilver" on influenza virus. DARU J Pharmaceutical Sci 2009, 17:88-93.
24. Shigeta S, Shuichi M, Junko W, Shu S, Kauzo T, Yamase T: Synergistic antiinfluenza virus A (H1N1) activities of PM-523 (Polyoxomatalate) and Ribavirin in vitro and in vivo. J Antimicrob Ag Chemoth 1997, 41:423-1427.
25. Godornes C, Leader BT, Molini BJ, Centurion-Lara A, Lukehart SA: Quantitation of rabbit cytokine mRNA by real-time RT-PCR. Cytokine 2007, 38:1-7. (Pubitemid 46990919)